Literature DB >> 17261137

Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study.

Abdul Malik1, Phaik-Leng Cheah, Ida Normiha Hilmi, Siew Pheng Chan, Khean-Lee Goh.   

Abstract

BACKGROUND AND OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is increasing rapidly in the Asia-Pacific region. There has been a paucity of studies from the region. The aims of this study were to define the demographic, anthropometric, metabolic and histological characteristics of patients with NAFLD in our local population and to determine independent predictors of severe liver fibrosis.
METHODS: Patients with persistently raised liver enzymes and/or fatty liver detected on ultrasonography with exclusion of other liver disorders were prospectively recruited. Their insulin resistance was assessed using the homeostasis model assessment of insulin resistance score. A liver biopsy was performed in all cases for grading (for steatohepatitis) and staging (for fibrosis) of NAFLD. Independent risk factors for fibrosis were determined using multiple logistic regression analysis.
RESULTS: Seventy-five patients were recruited: 39 men (52%) and 36 women (48%). The mean age of the patients was 47.0+/-12.2 years. Of these, 58 patients (77.3%) were centrally obese, 29 patients (38.7%) were diabetic and 15 patients (20.0%) had impaired glucose tolerance. Insulin resistance was diagnosed in 62 out of 64 (96.9%) patients. Benign steatosis, nonalcoholic steatohepatitis and cirrhosis were diagnosed in three (4.3%), 59 (84.3%) and eight (11.4%) of 70 patients, respectively. Significant independent predictors of liver fibrosis were; male sex (P=0.019, OR=5.55, CI=1.33-23.18) and Indian race (P=0.013, OR=8.21, CI=1.56-43.16).
CONCLUSIONS: The full histological spectrum of NAFLD was seen in our patients. The majority of patients were insulin resistant, centrally obese and either diabetic or had impaired glucose tolerance. The predictors of severe liver fibrosis were male sex and Indian race.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261137     DOI: 10.1111/j.1443-9573.2007.00286.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  12 in total

1.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

2.  Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia.

Authors:  Seok-Chin Goh; Evelyn Lai-Ming Ho; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2012-03-23       Impact factor: 6.047

3.  Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.

Authors:  Wah-Kheong Chan; Norhaniza Bahar; Hamizah Razlan; Anushya Vijayananthan; Pavai Sithaneshwar; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

4.  Association Between Elevated Liver Enzymes and Metabolic Syndrome Among Thai Adults.

Authors:  Sajithya Perera; Vitool Lohsoonthorn; Wiroj Jiamjarasrangsi; Somrat Lertmaharit; Michelle A Williams
Journal:  Diabetes Metab Syndr       Date:  2008-09

Review 5.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Authors:  Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2014-05-27

Review 6.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

Review 7.  Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?

Authors:  Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Ethnic differences in the prevalence of metabolic syndrome: results from a multi-ethnic population-based survey in Malaysia.

Authors:  Sanjay Rampal; Sanjiv Mahadeva; Eliseo Guallar; Awang Bulgiba; Rosmawati Mohamed; Ramlee Rahmat; Mohamad Taha Arif; Lekhraj Rampal
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.

Authors:  Samshol Sukahri; Fatimah Zaherah Mohamed Shah; Ahmad Izuanuddin Ismail; Marymol Koshy; Bushra Johari; Mazuin Mohd Razali; Thuhairah Hasrah Abdul Rahman; Mohamad Rodi Isa; Rohana Abdul Ghani
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

10.  Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Su Jong Yu; Won Kim; Donghee Kim; Jung-Hwan Yoon; Kyoungbun Lee; Jung Ho Kim; Eun Ju Cho; Jeong-Hoon Lee; Hwi Young Kim; Yoon Jun Kim; Chung Yong Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.